Ads
related to: atorvastatin usual dose amount for elderly female in early years
Search results
Results From The WOW.Com Content Network
Geriatric: Plasma concentrations of atorvastatin in healthy elderly subjects are higher than those in young adults. [3] However, clinical data suggests there is a similar reduction of LDL cholesterol and cardiovascular events at any dose in this population and adults younger than 65 years of age. [40] [41] [42]
For every 138 people treated for 5 years, one fewer dies; for every 49 treated, one fewer has an episode of heart disease. [11] A 2011 review reached similar conclusions, [25] and a 2012 review found benefits in both women and men. [26]
The average cost per DDD of rosuvastatin was 21% more expensive than atorvastatin ($1.14 compared to $0.94), which would suggest the shift at the time from prescribing atorvastatin to prescribing rosuvastatin would result in increased costs to the healthcare budget. Both had a DDD at that time of 10mg, but 10mg was not the only dose prescribed.
A new study has found that VO2 max is a better measure of cardiovascular health than body mass index (BMI). Here's what it is, plus how it's measured.
Hypercholesterolemia is not a risk factor for mortality in persons older than 70 years and risks from statin drugs are more increased after age 85. [2] Fibrates are indicated for hypertriglyceridemia. Fibrates typically lower triglycerides by 20% to 50%. Level of the good cholesterol HDL is also increased.
On average, domestic rabbits can live to be between 8 and 12 years old, says Blue Cross, a British animal welfare nonprofit. The oldest recorded domestic rabbit lived to be 18 years and 10 months ...
In the 20 years since Supernanny first aired, Frost has continued her work supporting families both on- and off-screen. Her TV series include Jo Frost: Extreme Parental Guidance, Family S.O.S., Jo ...
Ezetimibe/atorvastatin (trade names Liptruzet, Atozet) is a cholesterol lowering combination drug. In the United States, it was approved in May 2013, by the Food and Drug Administration for the treatment of elevated low-density lipoprotein (LDL) in patients with primary or mixed hyperlipidemia as adjunctive therapy to diet. [ 1 ]